Bisphosphonates or RANK‐ligand‐inhibitors for men with prostate cancer and bone metastases: a Cochrane Review and network meta‐analysis
| Autor: | Axel Heidenreich, Tina Jakob, Yonas Mehari Tesfamariam, S. Macherey, Nicole Skoetz, Kathrin Kuhr, Ina Monsef, Ingrid Becker |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2018 |
| Předmět: |
Oncology
Medicine General & Introductory Medical Sciences medicine.medical_specialty business.industry RANK Ligand medicine.disease 03 medical and health sciences Prostate cancer 0302 clinical medicine Text mining 030220 oncology & carcinogenesis Meta-analysis Internal medicine medicine Pharmacology (medical) 030212 general & internal medicine business |
| Zdroj: | The Cochrane Library |
| Popis: | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of bisphosphonates and RANK‐ligand (RANKL)‐inhibitors for supportive treatment in prostate cancer with bone metastases and to generate a clinically meaningful treatment ranking according to their safety and efficacy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|